The FDA has eased restrictions on drugs used to enhance ultrasound images of the heart.
Citing “serious cardiopulmonary reactions” and deaths, the agency slapped a black-box warning last fall on Definity, formerly sold by Bristol-Myers Squibb, and Optison, sold by GE. The warning said the drugs, known as contrast agents, shouldn’t be given to acutely ill [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment